One-hundred melanocytic lesions were evaluated for expression of MET and PD-L1 in a human tissue microarray (TMA) with benign nevi (17 patients), primary cutaneous melanomas (42 patients), primary mucosal melanomas (20 patients), and metastatic melanomas (21 patients). This evidence concerns the gene CD274 and metastatic melanoma.